New drug EDG-7500 put to the test in healthy volunteers
Knowledge-focused
Not yet recruiting
This early-stage study tests the safety of a new drug called EDG-7500 in 24 healthy adults, both Caucasian and Japanese. Participants receive single or multiple doses to see how the drug moves through the body. The goal is to gather safety and dosing information, not to treat any…
Phase: PHASE1 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 11:35 UTC